3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer

Pere Llinàs-Arias1, Miquel Ensenyat-Méndez1, Javier I J Orozco2

  • 1Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma, Spain.

BMC Genomic Data
|November 3, 2023
PubMed
Abstract

Insights

Researchers identified an epigenetic insulator element, IE8, crucial for triple-negative breast cancer (TNBC) cell invasion. Disrupting IE8 offers potential therapeutic targets for this aggressive cancer subtype.

Area of Science:

  • Genomics
  • Epigenetics
  • Cancer Biology

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options and frequent metastasis.
  • Understanding the epigenetic mechanisms driving TNBC dissemination is critical for developing targeted therapies.

Purpose of the Study:

  • To investigate epigenetic alterations contributing to TNBC cell invasion and metastasis.
  • To identify specific genomic elements involved in the dissemination process of TNBC.

Main Methods:

  • Utilized CRISPR/Cas9 to identify and disrupt the insulator element IE8 in TNBC cell models (MDA-MB-231, MDA-MB-436).
  • Generated high-resolution chromatin interaction (Hi-C), chromatin accessibility (ATAC-seq), and gene expression (RNA-seq) maps.
  • Analyzed multi-omics data to understand the spatial genome organization and molecular mechanisms of TNBC invasion.

Main Results:

  • Identified and functionally disrupted the insulator element IE8, demonstrating its relevance in TNBC cell invasion.
  • Generated comprehensive epigenetic and transcriptomic datasets for TNBC cell models.
  • Revealed significant changes in chromatin accessibility associated with TNBC cell invasion.

Conclusions:

  • The insulator element IE8 plays a role in TNBC cell invasion, presenting a potential therapeutic target.
  • The generated multi-omics data provide a valuable resource for future TNBC research.
  • Further investigation into IE8 and associated epigenetic changes may accelerate the discovery of novel TNBC treatments.